Article & News

Gubba Group
India’s problem of overtreatment, overmedication

Why in the NewsModern medicine’s growing power to test and treat is increasingly turning into overtreatment and overmedication: tests, medicines and procedures a patient does

Gubba Group
Aurobindo Pharma: Strong dose of growth opportunities

With key projects moving into commercial production, the drugmaker has stronger near-term growth visibility and also a long runwayAurobindo Pharma has developed multiple growth opportunities